EJNMMI Radiopharmacy and Chemistry
Scope & Guideline
Connecting researchers to inspire breakthroughs in radiopharmacy.
Introduction
Aims and Scopes
- Radiopharmaceutical Development:
The journal publishes research on the synthesis, characterization, and evaluation of new radiopharmaceuticals, focusing on their potential applications in imaging and therapy. - Automated Radiosynthesis:
A significant emphasis is placed on automated synthesis techniques that improve the production efficiency and reproducibility of radiopharmaceuticals, ensuring compliance with GMP standards. - Theranostic Applications:
Research articles often explore theranostic approaches that combine diagnostic imaging and targeted therapy, particularly in oncology, using radiolabeled compounds. - Quality Control and Regulatory Compliance:
The journal addresses best practices in quality control and regulatory frameworks for the production of radiopharmaceuticals, ensuring safety and efficacy in clinical settings. - Innovative Imaging Techniques:
There is a consistent focus on novel imaging methods and probes, including PET and SPECT, aimed at enhancing the diagnostic capabilities in various medical conditions, particularly cancer.
Trending and Emerging
- Precision Medicine and Targeted Therapies:
There is a growing emphasis on developing radiopharmaceuticals that are tailored for specific patient populations and disease types, particularly in cancer therapies, showcasing the trend towards personalized medicine. - Novel Radiometals and Radionuclides:
Research focusing on the use of new radiometals and radionuclides for imaging and therapeutic applications is on the rise, indicating a shift towards exploring alternatives to established isotopes. - Microfluidics and Automated Production Techniques:
Innovations in microfluidic systems for the production of radiopharmaceuticals are emerging as a key trend, enhancing the efficiency and scalability of radiotracer synthesis. - Biodistribution and Pharmacokinetics Studies:
An increased focus on understanding the biodistribution and pharmacokinetics of radiopharmaceuticals is evident, which is crucial for optimizing their clinical applications and improving safety profiles. - Regulatory Frameworks and Patient Access:
Research addressing the regulatory landscape and strategies to enhance patient access to radiopharmaceuticals is gaining traction, reflecting the importance of policy in the advancement of the field.
Declining or Waning
- Conventional Radiopharmaceuticals:
Research on traditional radiopharmaceuticals is becoming less frequent, as the field shifts towards more advanced and specific targeting agents, particularly in oncology. - Basic Radiochemistry Techniques:
While foundational radiochemistry methods remain important, there is a noticeable decline in publications focused solely on basic synthesis techniques without innovative applications or improvements. - Generalized Quality Control Practices:
There is a trend away from generic quality control discussions, as the journal increasingly emphasizes specific and novel methodologies tailored to particular radiopharmaceuticals.
Similar Journals
SEMINARS IN NUCLEAR MEDICINE
Elevating standards in nuclear medicine practice.Welcome to Seminars in Nuclear Medicine, a prestigious journal published by W B Saunders Co-Elsevier Inc that has been at the forefront of the field since its inception in 1971. This journal serves as a dedicated forum for researchers, healthcare professionals, and students specializing in the rapidly evolving areas of radiology and nuclear medicine. With an impressive ranking of #29 out of 333 in the Scopus category, drawing an esteemed 91st percentile, it holds a distinguished Q1 category status, highlighting its critical role in disseminating high-quality research and clinical practices. Although it does not operate as an Open Access publication, Seminars in Nuclear Medicine remains a vital resource, featuring comprehensive reviews and insightful articles that inform the medical community about the latest advancements and applications within nuclear imaging. This journal not only enhances knowledge but also encourages collaboration among professionals dedicated to improving patient outcomes through innovative nuclear medicine techniques.
American Journal of Nuclear Medicine and Molecular Imaging
Transforming Medical Insights with Cutting-Edge Imaging TechniquesThe American Journal of Nuclear Medicine and Molecular Imaging (ISSN: 2160-8407), published by E-CENTURY PUBLISHING CORP, is a distinguished platform for the dissemination of cutting-edge research in the fields of nuclear medicine and molecular imaging. With a commitment to advancing scientific inquiry and clinical applications, this journal serves as a vital resource for researchers, clinicians, and students dedicated to exploring innovative imaging modalities, radiopharmaceuticals, and their applications in diagnosing and treating various medical conditions. Although currently not available as an open-access journal, this publication plays a crucial role in fostering academic dialogue and collaboration within the medical community. Its diverse range of topics and expert contributions underscore its impact in bridging the gap between research findings and clinical practice, making it an essential read for anyone interested in the rapidly evolving landscape of nuclear medicine and imaging technologies.
RADIOCHEMISTRY
Exploring the Elements of Innovation in RadiochemistryRADIOCHEMISTRY, published by PLEIADES PUBLISHING INC, is a prominent journal focusing on the dynamic field of radiochemistry, encompassing both theoretical and experimental research in the application of radioactive elements and isotopes across various scientific domains. With the ISSN 1066-3622 and e-ISSN 1608-3288, this journal has been a vital resource for scholars since its inception, converging years of valuable research from 2003 to 2024. The journal currently holds a Q4 category quartile in the Physical and Theoretical Chemistry field, reflecting its niche position within this specialized discipline. Despite ranking #156 out of 189 in Scopus for Chemistry Physical and Theoretical Chemistry, with a 17th percentile ranking, RADIOCHEMISTRY continues to serve as an important forum for advancing knowledge and fostering collaboration among researchers and professionals dedicated to the study of radiochemical processes. Although it does not offer Open Access, researchers are encouraged to delve into its rich content for insights and advancements in radiochemistry.
Revista Espanola de Medicina Nuclear e Imagen Molecular
Bridging Theory and Practice in Radiology InnovationsRevista Española de Medicina Nuclear e Imagen Molecular, published by Elsevier España SLU, stands as a vital resource in the field of Radiology, Nuclear Medicine, and Molecular Imaging. With an ISSN of 2253-654X, this journal is committed to disseminating high-quality research and advancements in clinical practices, aiming to bridge the gap between theoretical research and application in healthcare. Operating since 2012, it features a robust archive of peer-reviewed articles and case studies, although it currently holds a Q4 ranking in the Scopus category, indicating significant potential for growth and influence within the academic community. The journal is indexed in Scopus, with a rank of 255 out of 333, placing it in the 23rd percentile, which underlines the need for increased contributions from researchers eager to enhance its standing. While it is not an open-access journal, its availability through libraries and institutions ensures that a wide audience can access critical findings and innovations in the rapidly evolving field of nuclear medicine. As we look towards the convergence period from 2012 to 2024, Revista Española de Medicina Nuclear e Imagen Molecular aspires to fortify its role as a cornerstone for collaboration and advancement in nuclear imaging and radiology.
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Connecting Researchers to Shape the Future of Imaging Science.The Quarterly Journal of Nuclear Medicine and Molecular Imaging, published by Edizioni Minerva Medica in Italy, serves as a pivotal platform for researchers and practitioners in the fields of Nuclear Medicine and Molecular Imaging. With an ISSN of 1824-4785 and an E-ISSN of 1827-1936, this journal boasts a respectable impact factor and is positioned in the Q3 quartile of the Radiology, Nuclear Medicine and Imaging category, based on the latest 2023 evaluations. As the journal continues to converge from its inception in 2004 to its anticipated expansions through 2024, it aims to disseminate high-quality, peer-reviewed articles that advance the frontier of imaging technologies and their applications in clinical practice. Researchers, professionals, and students are encouraged to contribute to its diverse scope, which encompasses innovative research, clinical findings, and reviews that encapsulate cutting-edge advancements in the field, highlighting its importance as an essential resource for knowledge and collaboration.
BMC MEDICAL IMAGING
Shaping Tomorrow's Imaging Solutions for Better Patient Care.BMC Medical Imaging is a premier open-access journal dedicated to advancing the field of radiology, nuclear medicine, and imaging technologies. Published by BMC in the United Kingdom, this journal serves as a vital resource for researchers, clinicians, and students, fostering a collaborative environment for sharing innovative findings and methodologies in medical imaging. With a commendable impact factor and an impressive Scopus ranking within the top 35% of its category, BMC Medical Imaging provides a platform for high-quality research to be disseminated widely and freely since its inception in 2001. The journal aims to cover a diverse array of topics, from advanced imaging techniques to their clinical applications, enhancing the understanding and effectiveness of diagnostic practices. By contributing to the body of knowledge and facilitating open access to research, BMC Medical Imaging plays a pivotal role in shaping the future of medical imaging and improving patient care.
NUCLEAR MEDICINE REVIEW
Connecting Researchers to Transformative Medical KnowledgeNUCLEAR MEDICINE REVIEW is a distinguished journal in the field of radiology, nuclear medicine, and imaging, published by VIA MEDICA in Poland. Since its transition to an open access format in 1999, this journal has been dedicated to promoting the dissemination of knowledge and research findings across a global audience. With a focus on innovative approaches and advancements in nuclear medicine, it aims to serve as a key resource for researchers, professionals, and students who are working to further the understanding of nuclear imaging and its applications. In 2023, the journal was classified in the Q3 category within Radiology, Nuclear Medicine and Imaging, and Q4 in the broader category of Medicine (miscellaneous), highlighting its growing reputation in the academic community. As of the latest assessments, the journal has been ranked #235 out of 333 in its field according to Scopus metrics, reflecting its commitment to excellence and the relevance of its published works. The NUCLEAR MEDICINE REVIEW is a pivotal platform for those engaged in cutting-edge research, providing insights that drive the evolution of medical imaging and therapeutic techniques.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Fostering Excellence in Nuclear Medicine ResearchThe European Journal of Nuclear Medicine and Molecular Imaging is a prestigious, peer-reviewed journal published by Springer, dedicated to advancing the field of nuclear medicine and molecular imaging. With an impressive impact factor and ranked in the Q1 category for both Medicine and Radiology, Nuclear Medicine and Imaging, this journal is a pivotal platform for researchers and practitioners to disseminate significant findings from 1996 to the present, reflecting the evolution of the field. The journal boasts a notable Scopus rank, standing at #8 out of 333 in its category, placing it in the top 3% of published works, which highlights its critical importance in shaping contemporary practices and research innovations. Although it does not offer an open-access model, the journal provides various access options to ensure that important research is accessible to professionals, students, and academics alike. Through rigorous peer review and a commitment to high-quality publication, the European Journal of Nuclear Medicine and Molecular Imaging plays an essential role in the advancement of nuclear medicine, contributing to better diagnostic and therapeutic outcomes globally.
CANCER IMAGING
Pioneering Insights for Enhanced Cancer CareCANCER IMAGING, published by BMC, stands as a leading open-access journal in the realms of oncology and medical imaging, significantly contributing to the advancement of cancer research since its inception in 2000. With an impressive impact across multiple domains—most notably ranking Q1 in prestigious categories such as Medicine (miscellaneous), Oncology, and Radiology—this journal ensures high visibility and influence within the academic community. As of 2023, it is recognized in various Scopus rankings, securing top positions in the fields of Radiology, Nuclear Medicine, and Imaging, alongside Radiological and Ultrasound Technology. The journal's commitment to open-access publication, adopted in 2014, enhances accessibility for researchers, healthcare professionals, and students alike, fostering an inclusive environment for sharing critical advancements and innovative methodologies in cancer imaging. Set in the vibrant landscape of the United Kingdom, CANCER IMAGING continues to play a vital role in elucidating the complexities of cancer diagnostics and treatment, establishing itself as an essential resource for those pursuing excellence in cancer care and research.
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY
Advancing Diagnostic Imaging through InnovationJOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, published by Lippincott Williams & Wilkins, stands as a vital resource in the field of Radiology, Nuclear Medicine, and Imaging. Since its inception in 1977, this journal has been dedicated to advancing the understanding and application of computer-assisted tomography, emphasizing innovative research and clinical practices that enhance diagnostic imaging techniques. With an impact factor reflective of its rigorous scholarship and relevance—ranking in the Q3 category—the journal serves as an essential platform for contributors and readers alike, navigating the challenges and opportunities within a rapidly evolving field. Researchers, professionals, and students are encouraged to engage with the rich repository of articles that cover emerging technologies, clinical applications, and theoretical advancements, collectively fostering a deeper comprehension of imaging sciences. Although not currently designated as an open-access journal, it continues to enhance discourse in the community from its headquarters in Philadelphia, PA, maintaining a commitment to the highest standards of academic excellence.